TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
133.81
-8.12 (-5.72%)
At close: Jan 21, 2026, 4:00 PM EST
135.32
+1.51 (1.13%)
After-hours: Jan 21, 2026, 7:59 PM EST
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $4.57 billion as of January 21, 2026. Its market cap has increased by 104.89% in one year.
Market Cap
4.57B
Enterprise Value
4.63B
1-Year Change
104.89%
Ranking
Category
Stock Price
$133.81
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $4.57B, an increase of 910.62%. That is a compound annual growth rate of 41.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 4.85B | 16.67% |
| Dec 31, 2025 | 4.16B | 98.67% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |